The ERCC2 gene trichothiodystrophy genetic test is a specialized diagnostic procedure aimed at identifying mutations in the ERCC2 gene, which are linked to trichothiodystrophy, a rare genetic disorder. This condition is characterized by brittle hair, intellectual disabilities, and physical growth delays, among other symptoms. The test is crucial for confirming the diagnosis, understanding the disease's progression, and facilitating appropriate medical and supportive care for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to detect any abnormalities in the ERCC2 gene that could indicate the presence of trichothiodystrophy. This high-precision test provides vital information for families and healthcare providers, enabling informed decisions about treatment options and management strategies.
The cost of the ERCC2 gene trichothiodystrophy genetic test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expert analysis required to accurately identify mutations in the ERCC2 gene. For families facing the challenges of trichothiodystrophy, this test represents a critical step towards achieving a better understanding of the condition and improving the quality of life for those affected.
The ERCC3 gene trichothiodystrophy genetic test is a specialized diagnostic tool used to identify mutations in the ERCC3 gene, which are associated with trichothiodystrophy, a rare genetic disorder. Trichothiodystrophy is characterized by brittle hair, intellectual disability, growth retardation, and photosensitivity, among other symptoms. The condition is inherited in an autosomal recessive pattern, meaning that two copies of the mutated gene, one from each parent, are necessary for the manifestation of the disorder.
This test involves analyzing the patient's DNA to look for specific mutations in the ERCC3 gene that are known to cause trichothiodystrophy. It is a crucial step in the diagnosis of the disorder, enabling healthcare providers to offer accurate genetic counseling to affected families, discuss potential treatment options, and manage the condition more effectively.
The test is available at DNA Labs UAE, a leading genetic testing facility known for its comprehensive range of diagnostic services. The cost of the ERCC3 gene trichothiodystrophy genetic test at DNA Labs UAE is 4400 AED. Given the complexity and the specialized nature of this test, it represents a significant step forward in the management and understanding of rare genetic disorders like trichothiodystrophy within the region.
The GTF2H5 gene plays a crucial role in the human body, being integral to the transcription factor IIH (TFIIH) complex, which is involved in nucleotide excision repair and transcription initiation. Mutations in this gene can lead to trichothiodystrophy, a rare autosomal recessive disorder characterized by brittle hair, intellectual disability, growth retardation, and photosensitivity, among other symptoms.
To diagnose this condition accurately, a genetic test targeting the GTF2H5 gene is available. This test is designed to identify mutations within the GTF2H5 gene that are responsible for trichothiodystrophy. It is a vital tool for confirming the diagnosis, which can then guide treatment and management decisions for affected individuals.
The test is offered at DNA Labs UAE, a leading facility in genetic diagnostics. The cost of the GTF2H5 gene trichothiodystrophy genetic test is set at 4400 AED. This test is conducted with high precision and accuracy, employing the latest in genetic testing technology to ensure reliable results. Individuals undergoing this test at DNA Labs UAE can expect comprehensive support, from pre-test counseling to understand the implications of the test, through to post-test counseling to discuss the results and potential next steps in the management or treatment of the condition.
The MPLKIP Gene Trichothiodystrophy Nonphotosensitive Type 1 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the MPLKIP gene. These mutations are known to cause Trichothiodystrophy Nonphotosensitive Type 1, a rare genetic condition characterized by brittle hair, intellectual disability, and reduced stature, among other symptoms, but without the photosensitivity often associated with other types of trichothiodystrophy. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect specific genetic alterations in the MPLKIP gene, providing crucial information for accurate diagnosis and potential management strategies for affected individuals and their families. This test is pivotal for early intervention and understanding the inheritance pattern of the condition, aiding in genetic counseling and future family planning.
The TUFT1 gene is crucial for dental enamel formation and development. A deficiency in the Tuftelin protein, encoded by the TUFT1 gene, can lead to dental anomalies and potentially affect bone mineralization. To identify individuals at risk of Tuftelin deficiency, a genetic test has been developed. This test specifically examines the TUFT1 gene for mutations that could lead to reduced or dysfunctional Tuftelin protein production.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the TUFT1 gene. The process involves collecting a DNA sample, typically through a non-invasive method such as a cheek swab or a blood draw. The sample is then analyzed using advanced genetic sequencing techniques to identify any mutations associated with Tuftelin deficiency.
The cost of the TUFT1 Gene Tuftelin Deficiency Genetic Test is set at 4400 AED. This price includes the collection of the sample, the genetic analysis, and a detailed report on the findings. The report not only provides information on the presence of any TUFT1 gene mutations but also offers insights into the potential health implications and recommendations for further steps, including genetic counseling if necessary.
This test is crucial for individuals with a family history of dental anomalies or those who have symptoms suggesting a deficiency in dental enamel formation. Early detection through this genetic test can lead to better management and treatment strategies, potentially mitigating the effects of the deficiency on dental and bone health.
The RHBDF2 gene tylosis with esophageal cancer genetic test is a specialized diagnostic procedure aimed at identifying mutations in the RHBDF2 gene, which are strongly linked to the development of tylosis with esophageal cancer (TOC). Tylosis is a rare genetic skin disorder characterized by thickening of the skin on the palms and soles, often associated with a high risk of developing esophageal cancer. The test is particularly crucial for individuals with a family history of tylosis or esophageal cancer, as it can provide vital information for early detection and management of these conditions.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the RHBDF2 gene. The results of this test can help healthcare providers develop a personalized monitoring and prevention strategy for affected individuals, potentially improving outcomes and quality of life.
The cost of the RHBDF2 gene tylosis with esophageal cancer genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to accurately detect the presence of mutations associated with this condition. Given the specialized nature of the test and the profound implications it can have for individuals and their families, the test represents a significant step forward in the personalized approach to healthcare and cancer prevention.
The DCLRE1C gene severe combined immunodeficiency Athabascan type genetic test is a specialized diagnostic assessment designed to identify mutations in the DCLRE1C gene, which are associated with a specific form of severe combined immunodeficiency (SCID), known as the Athabascan type. This rare and severe genetic disorder primarily affects the immune system, rendering individuals highly susceptible to a wide range of infectious diseases. The condition is particularly prevalent among certain indigenous populations, including the Athabascan people, hence the name.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in a laboratory setting to detect any genetic abnormalities in the DCLRE1C gene. Identifying mutations in this gene is crucial for the early diagnosis and management of the condition, allowing healthcare providers to initiate appropriate treatments and interventions, such as bone marrow transplants or gene therapy, to improve the patient's quality of life and survival chances.
Administered at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates, the test costs 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable test results. Early diagnosis through this genetic test is vital, as it provides critical information for managing the condition effectively, potentially saving lives and preventing severe complications associated with the disorder.
The RAG1 gene severe combined immunodeficiency B cell-negative genetic test is a specialized diagnostic procedure aimed at identifying mutations in the RAG1 gene, which are known to cause a type of severe combined immunodeficiency (SCID). This particular form of SCID is characterized by the absence of B cells, leading to significant vulnerabilities in the body's immune system. Patients with mutations in the RAG1 gene typically present with severe immunodeficiency, making them highly susceptible to infections.
The test is performed at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the test is set at 4400 AED, reflecting the sophisticated nature of the technology and expertise required to accurately identify mutations in the RAG1 gene. This test is crucial for early diagnosis and management of affected individuals, enabling healthcare providers to initiate appropriate treatments and interventions that can significantly improve the quality of life and survival rates of patients with this rare but severe condition.
The PTPRC Gene Severe Combined Immunodeficiency T Cell-Negative B-Cell Natural Killer Cell-Positive Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE. This genetic test is designed to identify mutations in the PTPRC gene, which plays a critical role in the development and function of the immune system. Mutations in this gene can lead to a rare form of Severe Combined Immunodeficiency (SCID), characterized by the absence of T cells, the presence of B cells, and normal or elevated numbers of natural killer (NK) cells. This specific immunodeficiency condition severely impairs the body's ability to fight infections, making early diagnosis crucial for effective treatment and management.
The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the state-of-the-art facilities of DNA Labs UAE. The lab employs advanced genetic sequencing techniques to accurately identify any mutations in the PTPRC gene. The results from this test can provide essential information for the diagnosis, treatment planning, and genetic counseling for affected individuals and their families. Given the critical nature of SCID, this test represents an important step in the early identification and management of the condition, potentially saving lives and improving the quality of life for those affected.
The IL7R Gene Severe Combined Immunodeficiency T-Cell Negative B-Cell Natural Killer Cell-Positive Type Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the IL7R gene. These mutations are associated with a specific form of Severe Combined Immunodeficiency (SCID), a rare genetic disorder characterized by the absence of T-cells, the presence of B-cells, and normal or elevated numbers of natural killer (NK) cells in patients. This condition significantly impairs the body's ability to fight infections, making early detection crucial for effective management and treatment.
The test involves analyzing the patient's DNA to identify any genetic abnormalities in the IL7R gene, which plays a critical role in the development and function of the immune system. By identifying mutations in this gene, healthcare providers can confirm a diagnosis of SCID, enabling them to tailor treatment strategies to the patient's specific needs, potentially including gene therapy, enzyme replacement therapy, or bone marrow transplantation.
Priced at 4400 AED, this genetic test is a valuable tool for families with a history of immunodeficiency disorders, offering them a chance for early intervention and improved health outcomes. Conducted at DNA Labs UAE, a facility known for its cutting-edge technology and expertise in genetic diagnostics, patients can expect reliable and accurate results, providing crucial information for managing this challenging condition.
